Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $40.38 million. The enterprise value is $50.02 million.
| Market Cap | 40.38M |
| Enterprise Value | 50.02M |
Important Dates
The last earnings date was Thursday, May 30, 2024, before market open.
| Earnings Date | May 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 37.56 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Shares Outstanding | 37.56M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.43% |
| Owned by Institutions (%) | 0.23% |
| Float | 14.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.06 |
| Forward PS | 8.74 |
| PB Ratio | 6.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.09.
| Current Ratio | 0.85 |
| Quick Ratio | 2.02 |
| Debt / Equity | 2.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.30 |
Financial Efficiency
Return on equity (ROE) is -93.10% and return on invested capital (ROIC) is -51.55%.
| Return on Equity (ROE) | -93.10% |
| Return on Assets (ROA) | -32.10% |
| Return on Capital (ROIC) | -51.55% |
| Revenue Per Employee | $111,268 |
| Profits Per Employee | -$167,217 |
| Employee Count | 45 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -558,873 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.66% in the last 52 weeks. The beta is -0.54, so Moolec Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.54 |
| 52-Week Price Change | -68.66% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 43.77 |
| Average Volume (20 Days) | 29,211 |
Short Selling Information
The latest short interest is 126,168, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 126,168 |
| Short Previous Month | 159,019 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 2.69 |
Income Statement
In the last 12 months, Moolec Science had revenue of $5.01 million and -$7.52 million in losses. Loss per share was -$0.16.
| Revenue | 5.01M |
| Gross Profit | 400,920 |
| Operating Income | -10.58M |
| Pretax Income | -8.08M |
| Net Income | -7.52M |
| EBITDA | -6.52M |
| EBIT | -7.37M |
| Loss Per Share | -$0.16 |
Balance Sheet
The company has $4.25 million in cash and $13.89 million in debt, giving a net cash position of -$9.64 million or -$0.26 per share.
| Cash & Cash Equivalents | 4.25M |
| Total Debt | 13.89M |
| Net Cash | -9.64M |
| Net Cash Per Share | -$0.26 |
| Equity (Book Value) | 6.64M |
| Book Value Per Share | 0.18 |
| Working Capital | -1.21M |
Cash Flow
In the last 12 months, operating cash flow was -$10.95 million and capital expenditures -$139,501, giving a free cash flow of -$11.09 million.
| Operating Cash Flow | -10.95M |
| Capital Expenditures | -139,501 |
| Free Cash Flow | -11.09M |
| FCF Per Share | -$0.30 |
Margins
Gross margin is 8.01%, with operating and profit margins of -211.34% and -150.28%.
| Gross Margin | 8.01% |
| Operating Margin | -211.34% |
| Pretax Margin | -161.44% |
| Profit Margin | -150.28% |
| EBITDA Margin | -130.15% |
| EBIT Margin | -147.15% |
| FCF Margin | -221.53% |
Dividends & Yields
Moolec Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -18.63% |
| FCF Yield | -27.47% |
Analyst Forecast
The average price target for Moolec Science is $6.00, which is 458.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 458.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 58.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Jan 3, 2023 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
Moolec Science has an Altman Z-Score of -2.97. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.97 |
| Piotroski F-Score | n/a |